Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Drug Combinations × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Thoracic 1 Sarcoma 1 Plasma cell 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Head & Neck 1 Genitourinary 1 Breast 1

Conditions

Interventions

Dexamethasone 725 Lenalidomide 385 Bortezomib 385 Cyclophosphamide 312 Melphalan 239 Calcium Dobesilate 221 daratumumab 199 pomalidomide 168 carfilzomib 146 fludarabine 114 Thalidomide 107 fludarabine phosphate 105 Peripheral Blood Stem Cell Transplantation 99 Filgrastim 99 ixazomib 81 dexamethasone acetate 74 Whole-Body Irradiation 74 Granulocyte Colony-Stimulating Factor 73 Mycophenolic Acid 69 Busulfan 69 dexamethasone 21-phosphate 62 Tacrolimus 61 auricularum 57 Prednisone 56 Cyclosporine 54 isatuximab 53 belantamab mafodotin 51 elotuzumab 48 Antilymphocyte Serum 48 Etoposide 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04065308 2019-08-22

Dara_DCEP

Seoul National University Hospital

Phase 2 Unknown

Plasmacytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡